Lv6
2340 积分 2023-10-09 加入
HPR27 US Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics, 1980–2024
7个月前
已完结
HPR27 US Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics, 1980–2024
7个月前
已完结
Reforming the Prescription Drug User Fee Program
7个月前
已完结
Impact of Rule 11 on the European Medical Software Landscape: Analysis of EUDAMED and Further Databases Three Years After MDR Implementation
7个月前
已完结
皖公网安备34019202002308
